ARK Genomic Revolution ETF vs iShares Russell 2000 ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.53, while iShares Russell 2000 ETF trades at $302.42. Which is the better fit depends on your goals.
| ARKG | IWM | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $44.55 | $301.69 |
52-Week Low | $24.02 | $225.45 |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IWM trades at $302.3, up 0.77% with a bullish technical outlook supported by moving averages, though RSI suggests mild overbought conditions. The ETF, tracking the Russell 2000 small-cap index, benefits from institutional favor due to deep liquidity and options markets. Small caps are outperforming large caps year-to-date, with the Russell 2000 up approximately 20% as of July 17, 2026 (24/7 Wall Street).
Outlook remains positive for small-cap exposure amid broadening market rally, but risks include higher volatility and economic sensitivity. Investors gain diversified small-cap access, yet should monitor valuation gaps versus alternatives and interest rate impacts highlighted by Goldman Sachs on July 7, 2026.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →